Shire Hits Par With Patent Suit Over Generic Adderall
Shire LLC slapped rival Par Pharmaceutical Inc. on Thursday with a patent infringement suit in New Jersey federal court over Par's application to market a generic version of Shire's attention deficit...To view the full article, register now.
Already a subscriber? Click here to view full article